Labilact capsules No. 10

composition

1 capsule contains: live lyophilized bacteria Lactobacillus acidophilus, Lactobacillus plantarum, Bifidobacterium bifidum, Bifidobacterium adolescerrtis -109 CFU/g; lactulose - 20 mg.

Properties

Lactobacteria are one of the dominant microorganisms of the normal microflora of the female genital tract, performing a protective function in the vagina. By fermenting glycogen of the vaginal epithelium, lactobacilli produce a number of organic acids that maintain low pH values in the vagina, the production of hydrogen peroxide by lactobacilli is one of the most important protective mechanisms, creating unfavorable conditions for the colonization and development of pathogenic microorganisms. Bifidobacteria are fixed on the surface of the epithelial cells of the vagina. They also belong to acid-producing microorganisms and participate in maintaining a low pH level. In addition, bifidobacteria produce bacteriocins, lysozyme, alcohols and are factors of colonization resistance of the vagina against pathogenic and conditionally pathogenic microorganisms.

Lactulose is a selective nutrient medium for the introduced bacteria. Its presence in the preparation Labilact allows the development of beneficial bacteria even in the absence of endogenous glycogen. The products of bacterial metabolism of lactulose (short-chain fatty acids) also reduce the pH of the vaginal contents.

Method of application

Labilact® is recommended for:

restoration of the composition of the normoflora after local and systemic use of antibiotics, antimicrobial, antifungal and non-steroidal anti-inflammatory drugs against sexually transmitted diseases, inflammatory diseases of the female genital organs; Prevention of diseases of the female genital organs accompanied by a violation of the normal microflora (candidiasis, gardnerellosis); correction of vaginal dysbiosis (candidiasis, gardnerellosis); normalization of the vaginal microflora during preparation for childbirth; reduction of clinical symptoms (itching, burning, discomfort) with systemic use of antibiotics, antimicrobial, antifungal and non-steroidal anti-inflammatory drugs against sexually transmitted diseases, inflammatory diseases of the female genital tract; renewal of the composition of the vaginal microflora in adolescence; reduction of the frequency of relapses of inflammatory diseases of the female genital tract; Prevention and use in the treatment of climacteric syndrome.

Method of application

Labilact® is used intravaginally. The vaginal capsule must be pre-moistened with boiled water and then inserted deep into the vagina. It is best to do this while lying on your back, with your knees slightly bent.

Treatment course: 1 vaginal capsule once a day for 10 days.
It is not recommended to exceed the specified dosage.
Labilact contains ingredients that may not completely disintegrate, capsule residues can sometimes be found on underwear. This does not affect the effectiveness of the drug.

Contraindication

Hypersensitivity to components.

Storage conditions

Store in a dry place, protected from light and out of reach of children.
Store at a temperature of 0°C to +25°C and a relative humidity of max. 75%.

Packaging form.

Vaginal capsules, 10 capsules in a blister.

Expiration date

12 months from the date of manufacture.